Volume 117, Issue S3 p. S35-S40
Article

Staging for Rhinosinusitis

Dr. Valerie J. Lund MS, FRCS, FRCSEd

Dr. Valerie J. Lund MS, FRCS, FRCSEd

Institute of Laryngology and Otology, University College London, London, United Kingdom

Search for more papers by this author
Dr. David W. Kennedy MD

Corresponding Author

Dr. David W. Kennedy MD

Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania

Reprint requests: David W. Kennedy, MD, Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsyvlania School of Medicine, Philadelphia, PA 19104Search for more papers by this author
First published: 17 May 2016
Citations: 248

Abstract

Interest in the surgical treatment of chronic rhinosinusitis has increased, primarily because rigid endoscopy and, more particularly, computed tomographic scanning have facilitated the visualization of disease. At the same time it has become both scientifically and financially imperative to audit therapeutic outcome. Consequently, a staging system for nonneoplastic sinus disease is needed. It is clear that any assessment of medical or surgical therapeutic response requires a method of quantifying disease severity that will be widely accepted by practitioners in the field. This acceptance will largely depend on how easy the method is to apply. With computed tomographic scanning it is possible to more accurately determine the extent of the pathologic condition in rhinosinusitis, a disease in which the severity of symptoms and the appearances on nasal endoscopy have a significantly more unpredictable correlation with the extent of disease. One goal of the Task Force on Rhinosinusitis of the American Academy of Otolaryngology-Head and Neck Surgery was to recommend a system for outcomes research that combines quantification with ease of application.